Ceftazidimeoffer
Ceftazidimeoffer is not a recognized term in pharmacology or medicine. It appears to be a concatenation of ceftazidime with the word “offer” and does not denote a distinct drug or approved indication. The following article describes ceftazidime itself, a third-generation cephalosporin antibiotic, independent of any marketing or promotional term.
Ceftazidime is a beta-lactam antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.
Clinical uses include treatment of moderate to severe infections caused by susceptible organisms, such as hospital-acquired
Administration and pharmacokinetics: Ceftazidime is given by intravenous or intramuscular injection. Dosing is adjusted for renal
Adverse effects and safety: Common events include diarrhea, nausea, rash, and phlebitis at injection sites. Hypersensitivity